|
Salicin based gut microbiome bacteria and enzymes
Salicin based gut microbiome bacteria and enzymes
Background
Inflammatory bowel disease (IBD) pertains to chronic inflammation of the gastrointestinal (GI) tract, and is classified either as ulcerative colitis, which commonly affects the large intestine and rectum, or Crohn’s disease, which affects the small intestine. While the exact cause...
Published: 6/26/2025
|
Updated: 5/31/2023
|
Inventor(s): Gavin Kuziel, Seth Rakoff-Nahoum
Keywords(s): Infectious Disease, Nutrition
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Therapeutics, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Gastroenterology, Technology Classifications > Invention Type > Therapeutics > Microbiome
|
|
MEMPHIS: Modular Evaluation of immunogenicity using Multi-Platform Human In vitro Systems
MEMPHIS: Modular Evaluation of immunogenicity using Multi-Platform Human In vitro Systems
Background
Though vaccination is one of the greatest accomplishments of modern medicine, there are still challenges to the production of perfectly effective vaccines. These challenges include weakened response by the vaccinated individual’s immune system...
Published: 3/24/2026
|
Updated: 5/31/2023
|
Inventor(s): Simon van Haren, Ofer Levy, Guzman Sanchez-Schmitz, David Dowling
Keywords(s): Drug Delivery, Immunology, Infectious Disease, Vaccine
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Research Tools, Technology Classifications > Invention Type > Research Tools > Assay, Technology Classifications > Invention Type > Vaccines, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Immunology, Technology Classifications > Disease Area > Infectious Disease
|
|
Toll-like receptor 2 agonists as vaccine adjuvants
Toll-like receptor 2 agonists as vaccine adjuvants
Background
Vaccinations play an essential role in preventing infections in the population, reducing the number of deaths in vulnerable individuals, as well as preventing endemics of highly infectious diseases. Because of the protective nature of vaccinations, particularly for those in certain vulnerable...
Published: 3/24/2026
|
Updated: 5/31/2023
|
Inventor(s): Ofer Levy, David Dowling, Francesco Borriello, Spencer Brightman
Keywords(s): Adjuvants, Infectious Disease, Vaccine
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Vaccines, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Infectious Disease, Technology Classifications > Disease Area > Oncology
|
